Information about the Department
The University Department of Oncology is one of the largest Departments in the School of Clinical Medicine at the University of Cambridge, encompassing members from both the University and NHS.
We are a diverse department, with approximately 90 graduate students and 400 staff members (70% University and 30% NHS), which includes academic Research Group Leaders and NHS consultants. We are also an integral part of the Regional Cancer Centre, established as one of 34 nationwide networks by the UK government in 2000 to improve delivery of cancer care throughout the UK.
Our mission is:
" To deliver the best possible care for patients, offer a world class environment for laboratory and clinical research and provide education and training programmes that generate world class oncology clinicians and research scientists".
The Department is based within 6 sites on or close to the Cambridge Biomedical Research Campus, which encompasses Addenbrooke's Hospital (the Cambridge University Teaching Hospital) and a number of internationally renowned Research Institutes and University of Cambridge Departments. Our location on the Biomedical Research Campus provides access to state of the art research and clinical facilities and enables close collaboration with world class laboratory scientists and clinicians. Please click on the following links for further information about our sites:
- Addenbrooke’s Department of Oncology & Cambridge Cancer Trials Centre,
- Anne McLaren Laboratory for Regenerative Medicine, MRC Centre for Stem Cell Biology & Regenerative Medicine,
- Cancer Research UK Cambridge Institute,
- Oncology at Hutchison/MRC Research Centre,
- Oncology at Strangeways Research laboratory,
- The Oncology Centre and
- Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute
Research within the Department focuses on developing and improving methods of diagnosis, treatment and prevention of cancers and is funded mainly by Cancer Research UK (CR-UK) , the Medical Research Council (MRC) and the National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre. Our research interests can be divided into 3 broad disciplines Basic Laboratory Research, Clinical & Translational Research and Clinical Trials. Many of our Research Group Leaders are also practising clinicians, which ensures strong links between our laboratory science and its clinical application.
The strength of our research was recognised in 2001, when the Regional Cancer Centre became designated as a translational research centre and in October 2006 when it was named as one of 17 centres for experimental cancer medicine in the country; information about the Experimental Cancer Medicine Centre (ECMC) Network can be found at: http://www.ecmcnetwork.org.uk//.
In the 2008 Research assessment Exercise (RAE), the Department staff featured in the University of Cambridge submission to the ''Cancer Studies Theme of Assessment', along with the Departments of Pathology and Haematology. The result of this assessment was that 35% of the profile of our submissions was awarded a 4* grading (world-leading in terms of originality, significance and rigour) and 40% was awarded a 3* grading (internationally excellent in terms of originality, significance and rigour). We were also ranked second in the Times Higher Education analysis of profiles submitted to the 'Cancer Studies Theme of Assessment'.
The Head of Department is >Professor Sir Bruce Ponder FRS, who was awarded a Knighthood for 'Services to Medicine' in the 2008 New Year's Honours list. Professor Sir Ponder is also Director of the Cancer Research UK Cambridge Research Institute; Director of the Cambridge Cancer Centre; Co-Director of the Hutchison/MRC Research Centre; former Co-Director of Oncology at Strangeways Research laboratory; Li Ka Shing Professor of Oncology; Honorary NHS Consultant and departmental Research Group Leader.